Minimally invasive gastrointestinal surgical systems market seen reaching $10.61 billion by 2030

The minimally invasive gastrointestinal surgical systems market is projected to grow from $7.22 billion in 2025 to $10.61 billion by 2030 as hospitals adopt robotic, AI and AR-guided tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - The market is expanding as hospitals and surgeons shift toward procedures that can reduce complications and speed recovery. - Growth in gastrointestinal disease cases is increasing demand for surgical systems built for small-incision and endoscopic procedures. - The forecast suggests continued investment in robotic, imaging and AI-enabled operating tools across healthcare systems.

What happened: - The Business Research Company released a 2026 report on the global minimally invasive gastrointestinal surgical systems market on August 18, 2026. - The market is projected to rise from $7.22 billion in 2025 to $7.81 billion in 2026. - The report forecasts the market will reach $10.61 billion by 2030. - The company said the market is growing on the back of robotic-assisted surgery, AR-guided technologies, hospital investment in minimally invasive infrastructure, surgeon training and AI-based surgical planning.

The details: - Minimally invasive gastrointestinal surgical systems are designed for procedures within the digestive tract through small incisions or natural body openings. - The systems combine advanced instruments with imaging technologies to improve precision and visualization. - The 2026 to 2030 forecast implies an 8.0% CAGR. - Historical drivers included continued use of traditional open surgeries, limited robotic availability, rising gastrointestinal disorder cases, laparoscopic instrument advances and broader use of standard endoscopic techniques. - The report cites rising adoption of minimally invasive gastrointestinal procedures, better imaging and visualization, single-incision approaches, natural orifice transluminal endoscopic surgery, robotic-assisted laparoscopic systems and a stronger focus on patient safety and faster recovery. - A sample report is available here. - The full report is available here. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - In 2025, North America held the largest share of the global market. - Asia-Pacific is expected to post the fastest growth during the forecast period.

Between the lines: - The report points to a market shaped by both clinical need and technology upgrades. - A 27% rise in gastrointestinal infection rates in England, from 96.1 per 100,000 in 2022 to 122.0 in 2024, underscores the growing disease burden behind demand. - The emphasis on AR, AI and robotics suggests competitive pressure is shifting toward higher-precision systems rather than basic procedural tools. - The inclusion of TAM analysis, company scoring matrices and forecasting dashboards signals a more strategy-focused report product for buyers.

What's next: - Hospitals are likely to keep expanding minimally invasive surgical capacity as digestive disease rates climb. - Surgeon training in advanced techniques should remain a key adoption driver. - Asia-Pacific’s growth trajectory may intensify as healthcare investment and medical infrastructure expand. - More suppliers are likely to push robotic-assisted and visualization-led systems as differentiation points.

The bottom line: - The minimally invasive gastrointestinal surgical systems market is on track for steady mid-single-digit billions in added value by 2030, led by technology adoption and rising gastrointestinal disease prevalence.